Carlyle chases potential four-bagger at biotech Opthea
SYDNEY: The Carlyle Group and its newly acquired life sciences arm, Abingworth, are seeking to
SYDNEY: The Carlyle Group and its newly acquired life sciences arm, Abingworth, are seeking to